|36.70||-0.15 / -0.41%|
Data as of 4:02pm ET
|36.71||+0.0098 / +0.03%|
The 5 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 40.00, with a high estimate of 44.00 and a low estimate of 19.00. The median estimate represents a +8.99% increase from the last price of 36.70.
The current consensus among 6 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.